Search Results

There are 13925 results for: content related to: Successful Transplantation of Reduced-Sized Rat Alcoholic Fatty Livers Made Possible by Mobilization of Host Stem Cells

  1. Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients

    Transfusion

    Volume 54, Issue 5, May 2014, Pages: 1243–1250, Ville Varmavuo, Johanna Rimpiläinen, Hanne Kuitunen, Anne Nihtinen, Kaija Vasala, Maija Mikkola, Anu Kutila, Päivi Lehtonen, Taru Kuittinen, Pentti Mäntymaa, Tapio Nousiainen, Outi Kuittinen and Esa Jantunen

    Version of Record online : 30 SEP 2013, DOI: 10.1111/trf.12434

  2. UK consensus statement on the use of plerixafor to facilitate autologous Peripheral Blood Stem Cell collection to support high-dose chemoradiotherapy for patients with malignancy

    Journal of Clinical Apheresis

    Kenneth W. Douglas, Maria Gilleece, Patrick Hayden, Hannah Hunter, Peter R. E. Johnson, Charlotte Kallmeyer, Ram K. Malladi, Shankara Paneesha, Rachel Pawson, Michael Quinn, Kavita Raj, Deborah Richardson, Stephen Robinson, Nigel Russell, John Snowden, Anna Sureda, Eleni Tholouli, Kirsty Thomson, Mike Watts and Keith M. Wilson

    Version of Record online : 20 JUN 2017, DOI: 10.1002/jca.21563

  3. Efficacy of just-in-time plerixafor rescue for Hodgkin's lymphoma patients with poor peripheral blood stem cell mobilization

    Transfusion

    Volume 54, Issue 8, August 2014, Pages: 2015–2021, Shan Yuan, Auayporn Nademanee, Mark Kaniewski, Joycelynne Palmer, Sepideh Shayani and Shirong Wang

    Version of Record online : 24 MAR 2014, DOI: 10.1111/trf.12594

  4. Evaluation of Dutch guideline for just-in-time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte–colony-stimulating factor

    Transfusion

    Volume 55, Issue 5, May 2015, Pages: 1021–1027, Yavuz M. Bilgin, Otto Visser, Erik A.M. Beckers, Liane CJ te Boome, Cynthia Huisman, Paula F. Ypma, Alexandra J. Croockewit, Tanja Netelenbos, Ellen PA Kramer and Georgine E. de Greef

    Version of Record online : 30 DEC 2014, DOI: 10.1111/trf.12979

  5. Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison

    Transfusion

    Volume 55, Issue 10, October 2015, Pages: 2358–2368, Jaakko Valtola, Ville Varmavuo, Antti Ropponen, Anne Nihtinen, Anu Partanen, Kaija Vasala, Päivi Lehtonen, Karri Penttilä, Marja Pyörälä, Taru Kuittinen, Raija Silvennoinen, Tapio Nousiainen, Jukka Pelkonen, Pentti Mäntymaa and Esa Jantunen

    Version of Record online : 28 MAY 2015, DOI: 10.1111/trf.13170

  6. A nationwide survey of the use of plerixafor in patients with lymphoid malignancies who mobilize poorly demonstrates the predominant use of the “on-demand” scheme of administration at French autologous hematopoietic stem cell transplant programs

    Transfusion

    Volume 55, Issue 9, September 2015, Pages: 2149–2157, Christian Chabannon, Fontanet Bijou, Jean-Michel Miclea, Noel Milpied, Jean-Marie Grouin and Mohamad Mohty

    Version of Record online : 13 MAY 2015, DOI: 10.1111/trf.13141

  7. You have full text access to this OnlineOpen article
    Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma

    Transfusion

    Volume 55, Issue 2, February 2015, Pages: 275–283, Jian Cheng, Michael Schmitt, Patrick Wuchter, Eike C. Buss, Mathias Witzens-Harig, Kai Neben, Michael Hundemer, Jens Hillengass, Renate Alexi, Hartmut Goldschmidt, Bao-an Chen, Anthony D. Ho and Anita Schmitt

    Version of Record online : 13 AUG 2014, DOI: 10.1111/trf.12813

  8. Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept

    Transfusion

    Volume 52, Issue 4, April 2012, Pages: 906–914, Esa Jantunen and Roberto M. Lemoli

    Version of Record online : 7 OCT 2011, DOI: 10.1111/j.1537-2995.2011.03349.x

  9. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models

    The Prostate

    Volume 75, Issue 12, September 1, 2015, Pages: 1227–1246, Giovanni Luca Gravina, Andrea Mancini, Paola Muzi, Luca Ventura, Leda Biordi, Enrico Ricevuto, Simona Pompili, Claudia Mattei, Ernesto Di Cesare, Emmanuele A. Jannini and Claudio Festuccia

    Version of Record online : 12 JUN 2015, DOI: 10.1002/pros.23007

  10. You have full text access to this OnlineOpen article
    The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by “on-demand” addition of plerixafor to granulocyte–colony-stimulating factor

    Transfusion

    Volume 54, Issue 9, September 2014, Pages: 2325–2335, Tamara Girbl, Verena Lunzer, Richard Greil, Konrad Namberger and Tanja Nicole Hartmann

    Version of Record online : 28 MAR 2014, DOI: 10.1111/trf.12632

  11. You have free access to this content
    Patients' outcome after rescue plerixafor administration for autologous stem cell mobilization: a single-center retrospective analysis

    Transfusion

    Volume 57, Issue 1, January 2017, Pages: 115–121, Silvia Spoerl, Robert Peter, Dagmar Wäscher, Katharina Götze, Mareike Verbeek, Christian Peschel and Angela M. Krackhardt

    Version of Record online : 18 NOV 2016, DOI: 10.1111/trf.13883

  12. You have free access to this content
    Retrospective comparison of filgrastim plus plerixafor to other regimens for remobilization after primary mobilization failure: Clinical and economic outcomes

    American Journal of Hematology

    Volume 87, Issue 7, July 2012, Pages: 673–677, Janelle B. Perkins, Jamie F. Shapiro, Ryan N. Bookout, Gary C. Yee, Claudio Anasetti, William E. Janssen and Hugo F. Fernandez

    Version of Record online : 3 JUN 2012, DOI: 10.1002/ajh.23221

  13. You have free access to this content
    Mobilization strategies in hard-to-mobilize patients with lymphoid malignancies

    European Journal of Haematology

    Volume 85, Issue 6, December 2010, Pages: 463–471, Esa Jantunen and Gunnar Kvalheim

    Version of Record online : 11 NOV 2010, DOI: 10.1111/j.1600-0609.2010.01520.x

  14. Prospective study of mobilization kinetics up to 18 hours after late-afternoon dosing of plerixafor

    Transfusion

    Volume 54, Issue 5, May 2014, Pages: 1263–1268, Patricia A. Shi, Lorraine K. Miller and Luis M. Isola

    Version of Record online : 16 OCT 2013, DOI: 10.1111/trf.12459

  15. Impact of plerixafor (mozobil) on hospital efficiency: a single center experience

    Journal of Clinical Apheresis

    Nabih Azar, Maya Ouzegdouh, Sylvain Choquet and Véronique Leblond

    Version of Record online : 28 APR 2017, DOI: 10.1002/jca.21551

  16. You have free access to this content
    A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers

    British Journal of Haematology

    Volume 153, Issue 1, April 2011, Pages: 66–75, Steven J. Lemery, Matthew M. Hsieh, Aleah Smith, Sheila Rao, Hanh M. Khuu, Donohue Theresa, Jennifer M. Viano, Lisa Cook, Rose Goodwin, Carol Boss, Gary Calandra, Nancy Geller, John Tisdale and Richard Childs

    Version of Record online : 24 FEB 2011, DOI: 10.1111/j.1365-2141.2010.08547.x

  17. Efficacy of pre-emptively used plerixafor in patients mobilizing poorly after chemomobilization: a single centre experience

    European Journal of Haematology

    Volume 86, Issue 4, April 2011, Pages: 299–304, Esa Jantunen, Taru Kuittinen, Eija Mahlamäki, Marja Pyörälä, Pentti Mäntymaa and Tapio Nousiainen

    Version of Record online : 31 JAN 2011, DOI: 10.1111/j.1600-0609.2010.01573.x

  18. Second time a charm? Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agent

    Transfusion

    Volume 53, Issue 12, December 2013, Pages: 3244–3250, Shan Yuan, Auayporn Nademanee, Amrita Krishnan, Neil Kogut, Sepideh Shayani and Shirong Wang

    Version of Record online : 22 APR 2013, DOI: 10.1111/trf.12198

  19. Plerixafor in combination with granulocyte–colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial

    Transfusion

    Volume 55, Issue 10, October 2015, Pages: 2351–2357, Neera Jagirdar, R. Donald Harvey, Ajay Nooka, Christopher Flowers, Jonathan Kaufman, Sagar Lonial, Mary Jo Lechowicz, Amelia Langston, Carol Lipscomb, Cynthia Gaylor and Edmund K. Waller

    Version of Record online : 2 SEP 2015, DOI: 10.1111/trf.13186

  20. Plerixafor: A Peripheral Blood Stem Cell Mobilizer

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 5, May 2010, Pages: 485–492, Dr. Mika R. Kessans, Dr. Mandy L. Gatesman and Dr. Denise R. Kockler

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.30.5.485